MeSH term
Frequency | Condition_Probility | Cell Adhesion Molecules/*metabolism | 9 | 3.0 |
Cell Movement/*physiology | 5 | 2.0 |
Comparative Study | 7 | 0.0 |
Hela Cells | 7 | 0.0 |
Humans | 70 | 0.0 |
Microfilaments/*metabolism | 2 | 8.0 |
Microspheres | 2 | 1.0 |
Phosphoproteins/*metabolism | 12 | 2.0 |
Animals | 38 | 0.0 |
Carrier Proteins/metabolism | 2 | 0.0 |
Cell Adhesion Molecules/genetics/*metabolism | 7 | 16.0 |
Cells, Cultured | 18 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/*metabolism | 3 | 3.0 |
*Cytoskeletal Proteins | 6 | 5.0 |
Fibroblasts/cytology/metabolism | 2 | 1.0 |
Mice | 13 | 0.0 |
Phosphoproteins/genetics/*metabolism | 7 | 4.0 |
Phosphorylation | 23 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Calcium/metabolism | 2 | 0.0 |
Time Factors | 6 | 0.0 |
Blotting, Western | 6 | 0.0 |
Calcium/*metabolism | 2 | 0.0 |
Cell Line | 6 | 0.0 |
Cyclic AMP-Dependent Protein Kinases/metabolism | 3 | 1.0 |
Membrane Proteins/metabolism | 3 | 0.0 |
Transfection | 5 | 0.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
Models, Biological | 5 | 0.0 |
Cell Adhesion Molecules/metabolism | 5 | 2.0 |
Cyclic GMP/*metabolism | 4 | 11.0 |
Cyclic GMP-Dependent Protein Kinases/metabolism | 4 | 36.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Female | 9 | 0.0 |
Immunohistochemistry | 5 | 0.0 |
In Vitro | 5 | 0.0 |
Male | 8 | 0.0 |
Middle Aged | 4 | 0.0 |
Nitric Oxide/*metabolism | 2 | 1.0 |
Phosphoproteins/metabolism | 5 | 0.0 |
Phosphorylation/drug effects | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 51 | 0.0 |
Base Sequence | 8 | 0.0 |
DNA Primers | 6 | 0.0 |
Fluorescent Antibody Technique | 5 | 0.0 |
Blood Proteins/metabolism | 2 | 0.0 |
Microfilament Proteins/metabolism | 8 | 9.0 |
Pregnancy | 2 | 0.0 |
Actins/*metabolism | 10 | 4.0 |
Cytoskeleton/metabolism | 2 | 0.0 |
Membrane Proteins/genetics/*metabolism | 2 | 0.0 |
*Signal Transduction | 3 | 0.0 |
Fibroblasts | 2 | 0.0 |
Rats | 10 | 0.0 |
Vinculin/*metabolism | 2 | 40.0 |
Amino Acid Sequence | 20 | 0.0 |
Molecular Sequence Data | 19 | 0.0 |
Tumor Cells, Cultured | 2 | 0.0 |
Binding Sites | 6 | 0.0 |
Protein Binding | 12 | 0.0 |
Conserved Sequence | 2 | 0.0 |
Kinetics | 6 | 0.0 |
Listeria monocytogenes/genetics/*physiology | 2 | 100.0 |
Models, Chemical | 2 | 0.0 |
Movement | 3 | 5.0 |
Mutagenesis, Site-Directed | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Rabbits | 4 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Aorta | 2 | 1.0 |
Enzyme Activation | 3 | 0.0 |
Microscopy, Fluorescence | 2 | 0.0 |
Blood Platelets/*metabolism | 5 | 1.0 |
Cell Nucleus/metabolism | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 5 | 0.0 |
Pseudopodia/metabolism | 2 | 6.0 |
Binding, Competitive | 2 | 0.0 |
Cell Adhesion Molecules/*chemistry | 2 | 12.0 |
*Contractile Proteins | 5 | 29.0 |
Fibroblasts/metabolism | 3 | 0.0 |
Lymphocyte Activation | 2 | 0.0 |
Phosphoproteins/*chemistry | 2 | 6.0 |
Proline/metabolism | 2 | 3.0 |
Cell Adhesion | 4 | 0.0 |
Cloning, Molecular | 4 | 0.0 |
Metalloproteins/metabolism | 2 | 16.0 |
Precipitin Tests | 2 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
Vinculin/metabolism | 2 | 8.0 |
Mutation | 3 | 0.0 |
Cell Adhesion Molecules/chemistry/*metabolism | 2 | 22.0 |
Phosphoproteins/chemistry/*metabolism | 3 | 5.0 |
Nitroprusside/pharmacology | 7 | 9.0 |
Vasodilator Agents/pharmacology | 3 | 5.0 |
Treatment Outcome | 3 | 0.0 |
3T3 Cells | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
Swine | 2 | 0.0 |
Blood Platelets/cytology/metabolism | 2 | 28.0 |
Cattle | 2 | 0.0 |
DNA-Binding Proteins/genetics/*metabolism | 2 | 0.0 |
Adenosine Diphosphate/pharmacology | 2 | 1.0 |
Adult | 3 | 0.0 |
Calcium/physiology | 2 | 0.0 |
Cyclic AMP/blood | 4 | 11.0 |
Platelet Aggregation Inhibitors/*pharmacology | 3 | 4.0 |
Cell Adhesion Molecules/chemistry/genetics/*metabolism | 2 | 33.0 |
Mutagenesis | 2 | 0.0 |
Phosphoproteins/chemistry/genetics/*metabolism | 2 | 4.0 |
DNA, Complementary | 2 | 0.0 |
Mice, Knockout | 2 | 0.0 |
Platelet Activation/*physiology | 2 | 3.0 |
Cell Adhesion Molecules/chemistry/genetics/*physiology | 2 | 66.0 |
Phosphoproteins/chemistry/genetics/*physiology | 2 | 28.0 |
*Protein Processing, Post-Translational | 2 | 0.0 |
Rats, Inbred F344 | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Microscopy, Immunoelectron | 2 | 0.0 |
Actins/metabolism | 4 | 0.0 |
Alprostadil/pharmacology | 5 | 19.0 |
Signal Transduction | 2 | 0.0 |
Microfilament Proteins/*metabolism | 3 | 4.0 |
Chickens | 2 | 0.0 |
Cell Adhesion Molecules/*biosynthesis | 2 | 2.0 |
Phosphoproteins/*biosynthesis | 2 | 10.0 |
Autoradiography | 3 | 0.0 |
Platelet Aggregation Inhibitors/pharmacology | 3 | 4.0 |
Mammals | 2 | 0.0 |
Molecular Weight | 3 | 0.0 |
Peptide Fragments/chemistry/isolation & purification | 2 | 5.0 |
Cell Compartmentation | 2 | 0.0 |
Dogs | 2 | 0.0 |
Blood Platelets/*drug effects/metabolism | 2 | 5.0 |
Cyclic AMP/*metabolism | 3 | 1.0 |
Blood Proteins/*metabolism | 3 | 1.0 |
Membrane Proteins/*blood | 2 | 3.0 |
Phosphoserine/analysis | 2 | 11.0 |
Vasodilator Agents/*pharmacology | 4 | 8.0 |
Cyclic GMP/blood | 2 | 14.0 |
Cell Adhesion Molecules/*chemistry/physiology | 2 | 66.0 |
Phosphoproteins/*chemistry/physiology | 2 | 66.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Enzyme Inhibitors/pharmacology | 2 | 0.0 |
Phosphodiesterase Inhibitors/pharmacology | 2 | 1.0 |
Reference Values | 2 | 0.0 |
